BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37411030)

  • 1. Effects of the ARRIVE (A Randomized Trial of Induction Versus Expectant Management) Trial on Elective Induction and Obstetric Outcomes in Term Nulliparous Patients.
    Nethery E; Levy B; McLean K; Sitcov K; Souter VL
    Obstet Gynecol; 2023 Aug; 142(2):242-250. PubMed ID: 37411030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal and newborn outcomes with elective induction of labor at term.
    Souter V; Painter I; Sitcov K; Caughey AB
    Am J Obstet Gynecol; 2019 Mar; 220(3):273.e1-273.e11. PubMed ID: 30716284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An hypothetical external validation of the ARRIVE trial in a European academic hospital.
    Tassis BMG; Ruggiero M; Ronchi A; Ramezzana IG; Bischetti G; Iurlaro E; D'Ambrosi F; Ciralli F; Mosca F; Ferrazzi EM
    J Matern Fetal Neonatal Med; 2022 Nov; 35(22):4291-4298. PubMed ID: 33207972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Rates of Hypertensive Disorders of Pregnancy Among Nulliparous Patients After the ARRIVE (A Randomized Trial of Induction Versus Expectant Management) Trial.
    Futterman ID; Gilroy LC; Silver M; Minkoff H; Al-Kouatly HB; McLaren RA
    Obstet Gynecol; 2023 Aug; 142(2):239-241. PubMed ID: 37473407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in obstetrical practices and pregnancy outcomes following the ARRIVE trial.
    Gilroy LC; Al-Kouatly HB; Minkoff HL; McLaren RA
    Am J Obstet Gynecol; 2022 May; 226(5):716.e1-716.e12. PubMed ID: 35139334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of labour for improving birth outcomes for women at or beyond term.
    Middleton P; Shepherd E; Crowther CA
    Cochrane Database Syst Rev; 2018 May; 5(5):CD004945. PubMed ID: 29741208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elective induction of labor at 39 weeks compared with expectant management: a meta-analysis of cohort studies.
    Grobman WA; Caughey AB
    Am J Obstet Gynecol; 2019 Oct; 221(4):304-310. PubMed ID: 30817905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal and neonatal outcomes of elective induction of labor.
    Caughey AB; Sundaram V; Kaimal AJ; Cheng YW; Gienger A; Little SE; Lee JF; Wong L; Shaffer BL; Tran SH; Padula A; McDonald KM; Long EF; Owens DK; Bravata DM
    Evid Rep Technol Assess (Full Rep); 2009 Mar; (176):1-257. PubMed ID: 19408970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of labor at 39 weeks of gestation versus expectant management for low-risk nulliparous women: a cost-effectiveness analysis.
    Hersh AR; Skeith AE; Sargent JA; Caughey AB
    Am J Obstet Gynecol; 2019 Jun; 220(6):590.e1-590.e10. PubMed ID: 30768934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Labor induction at 41
    Place K; Rahkonen L; Tekay A; Väyrynen K; Orden MR; Vääräsmäki M; Uotila J; Tihtonen K; Rinne K; Mäkikallio K; Heinonen S; Kruit H
    Acta Obstet Gynecol Scand; 2024 Mar; 103(3):505-511. PubMed ID: 38112629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal and Perinatal Outcomes of Expectant Management of Full-Term, Low-Risk, Nulliparous Patients.
    Tita ATN; Doherty L; Grobman WA; Reddy UM; Silver RM; Mallett G; Rice MM; El-Sayed YY; Wapner RJ; Rouse DJ; Saade GR; Thorp JM; Chauhan SP; Costantine MM; Chien EK; Casey BM; Srinivas SK; Swamy GK; Simhan HN; Macones GA;
    Obstet Gynecol; 2021 Feb; 137(2):250-257. PubMed ID: 33416294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elective Induction of Labor Compared With Expectant Management of Nulliparous Women at 39 Weeks of Gestation: A Randomized Controlled Trial.
    Miller NR; Cypher RL; Foglia LM; Pates JA; Nielsen PE
    Obstet Gynecol; 2015 Dec; 126(6):1258-1264. PubMed ID: 26551184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants.
    Biesty LM; Egan AM; Dunne F; Dempsey E; Meskell P; Smith V; Ni Bhuinneain GM; Devane D
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012910. PubMed ID: 29303230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of labour at 41 weeks or expectant management until 42 weeks: A systematic review and an individual participant data meta-analysis of randomised trials.
    Alkmark M; Keulen JKJ; Kortekaas JC; Bergh C; van Dillen J; Duijnhoven RG; Hagberg H; Mol BW; Molin M; van der Post JAM; Saltvedt S; Wikström AK; Wennerholm UB; de Miranda E
    PLoS Med; 2020 Dec; 17(12):e1003436. PubMed ID: 33290410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal and perinatal outcomes after elective induction of labor at 39 weeks in uncomplicated singleton pregnancy: a meta-analysis.
    Sotiriadis A; Petousis S; Thilaganathan B; Figueras F; Martins WP; Odibo AO; Dinas K; Hyett J
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):26-35. PubMed ID: 30298532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Labor Induction versus Expectant Management in Low-Risk Nulliparous Women.
    Grobman WA; Rice MM; Reddy UM; Tita ATN; Silver RM; Mallett G; Hill K; Thom EA; El-Sayed YY; Perez-Delboy A; Rouse DJ; Saade GR; Boggess KA; Chauhan SP; Iams JD; Chien EK; Casey BM; Gibbs RS; Srinivas SK; Swamy GK; Simhan HN; Macones GA;
    N Engl J Med; 2018 Aug; 379(6):513-523. PubMed ID: 30089070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in low-risk patients before and after an institutional policy offering 39-week elective induction of labor.
    Cozzi-Glaser GD; Blanchard CT; Stanford JN; Oben AG; Jauk VC; Szychowski JM; Subramaniam A; Battarbee AN; Casey BM; Tita AT; Sinkey RG
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2295223. PubMed ID: 38124289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension in pregnancy and adverse outcomes among low-risk nulliparous women expectantly managed at or after 39 weeks: a secondary analysis of a randomised controlled trial.
    Fishel Bartal M; Premkumar A; Murguia Rice M; Reddy UM; Tita ATN; Silver RM; El-Sayed YY; Wapner RJ; Rouse DJ; Saade GR; Thorp JM; Costantine MM; Chien EK; Casey BM; Srinivas SK; Swamy GK; Simhan HN;
    BJOG; 2022 Jul; 129(8):1396-1403. PubMed ID: 34927787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Maternal Labor-Related Complications and Neonatal Outcomes Following Elective Induction of Labor at 39 Weeks of Gestation vs Expectant Management: A Systematic Review and Meta-analysis.
    Hong J; Atkinson J; Roddy Mitchell A; Tong S; Walker SP; Middleton A; Lindquist A; Hastie R
    JAMA Netw Open; 2023 May; 6(5):e2313162. PubMed ID: 37171818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elective induction of labor at term compared with expectant management: maternal and neonatal outcomes.
    Darney BG; Snowden JM; Cheng YW; Jacob L; Nicholson JM; Kaimal A; Dublin S; Getahun D; Caughey AB
    Obstet Gynecol; 2013 Oct; 122(4):761-769. PubMed ID: 24084532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.